Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Jun 12, 2024 | 12.00 | +1.69 |
Oak Valley Bancorp | OVLY | Jun 12, 2024 | 24.03 | +0.42 |
Oak Woods Acquisition | OAKU | Jun 12, 2024 | 10.82 | 0.00 |
Oaktree Capital A Pref | OAK-A | Jun 12, 2024 | 21.52 | +0.90 |
Oaktree Capital Group B Pref | OAK-B | Jun 12, 2024 | 21.27 | +1.00 |
Oaktree Specialty | OCSL | Jun 12, 2024 | 19.50 | -0.20 |
Oatly ADR | OTLY | Jun 12, 2024 | 0.99 | -0.42 |
Oblong | OBLG | Jun 12, 2024 | 0.18 | -10.50 |
OCA Acquisition A | OCAX | Jun 12, 2024 | 11.13 | 0.00 |
Occidental Petroleum | OXY | Jun 12, 2024 | 60.30 | -0.51 |
Ocean Biomedical | OCEA | Jun 12, 2024 | 1.44 | -10.00 |
Ocean Power Technologies | OPTT | Jun 12, 2024 | 0.15 | +5.29 |
Oceaneering International | OII | Jun 12, 2024 | 22.06 | +2.80 |
OceanFirst Financial | OCFC | Jun 12, 2024 | 14.99 | +3.88 |
OceanFirst Pref | OCFCP | Jun 12, 2024 | 24.73 | +0.33 |
OceanPal | OP | Jun 12, 2024 | 2.05 | -4.21 |
Ocugen | OCGN | Jun 12, 2024 | 1.54 | +0.98 |
Ocular Therapeutix | OCUL | Jun 12, 2024 | 4.93 | -1.79 |
Oculis | OCS | Jun 12, 2024 | 11.85 | -0.59 |
Ocuphire Pharma | OCUP | Jun 12, 2024 | 1.72 | +0.29 |
Ocwen Financial | OCN | Jun 12, 2024 | 25.08 | 0.00 |
Oddity Tech | ODD | Jun 12, 2024 | 42.30 | -3.40 |
Odyssey Marine Exploration | OMEX | Jun 12, 2024 | 5.46 | +6.23 |
Offerpad Solutions A | OPAD | Jun 12, 2024 | 5.01 | +2.87 |
Office Properties | OPI | Jun 12, 2024 | 2.19 | -3.52 |
OFG Bancorp | OFG | Jun 12, 2024 | 36.69 | +1.30 |
OFS Capital | OFS | Jun 12, 2024 | 9.94 | +1.33 |
OFS Credit | OCCI | Jun 12, 2024 | 7.49 | -1.25 |
OFS Credit C Pref | OCCIO | Jun 12, 2024 | 24.16 | +0.04 |
OFS Credit E Pref | OCCIN | Jun 12, 2024 | 23.32 | +0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.